Patents by Inventor Camilla Svensson

Camilla Svensson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10940126
    Abstract: Pain associated with a contribution of IL-8 and osteoclasts in a subject is prevented, treated and/or alleviated by the administration of an effective amount of a compound capable of inhibiting or blocking the action of interleukin 8 (IL-8). Methods and compounds for this use are disclosed, as well as a diagnostic method and kit.
    Type: Grant
    Filed: December 29, 2016
    Date of Patent: March 9, 2021
    Inventors: Camilla Svensson, Lars Klareskog, Vivianne Malmstrom, Anca Catrina
  • Publication number: 20170181987
    Abstract: Pain associated with a contribution of IL-8 and osteoclasts in a subject is prevented, treated and/or alleviated by the administration of an effective amount of a compound capable of inhibiting or blocking the action of interleukin 8 (IL-8). Methods and compounds for this use are disclosed, as well as a diagnostic method and kit.
    Type: Application
    Filed: December 29, 2016
    Publication date: June 29, 2017
    Inventors: Camilla SVENSSON, Lars KLARESKOG, Vivianne MALMSTROM, Anca CATRINA
  • Publication number: 20170105971
    Abstract: Bone loss and/or pain associated with an elevated activation of osteoclasts is prevented, treated and/or alleviated by the administration of an effective amount of a compound capable of inhibiting the activity of a peptidylarginine deiminase (PAD) enzyme. Methods and compounds for this use are disclosed, as well as diagnostic methods, kits, and a method for identifying compounds effective to prevent, treat and/or alleviate bone loss and/or pain.
    Type: Application
    Filed: December 29, 2016
    Publication date: April 20, 2017
    Inventors: Anca CATRINA, Camilla SVENSSON, Lars KLARESKOG, Vivianne MALMSTROM
  • Patent number: 7745489
    Abstract: Specific, highly potent 2-oxo-amide based inhibitors of phospholipase A2 (PLA2) activity are provided. A role for PLA2 activity in spinally mediated inflammatory processes is established, and a method for treating hyperalgesia and other inflammatory conditions associated with PLA2 activity is provided.
    Type: Grant
    Filed: March 7, 2003
    Date of Patent: June 29, 2010
    Assignee: The Regents of the University of California
    Inventors: Edward Dennis, Tony Yaksh, Karin Killermann Lucas, Camilla Svensson, David A. Six, George Kokotos, Violetta Constantinou-Kokotou
  • Publication number: 20080319065
    Abstract: Phospholipase A2 (PLA2) forins are expressed in spinal cord whose inhibition induces a potent antihyperalgesia. PLA2 inhibitor compounds are provided that include a common motif consisting of a 2-oxoamide with a hydrocarbon tail and a four carbon tether. The compounds block Group IVA calcium dependent PLA2 (cPLA2) and/or Group VIA calcium independent PLA2 (iPLA2) and/or Group V secreted PLA2 (sPLA2).
    Type: Application
    Filed: August 17, 2006
    Publication date: December 25, 2008
    Inventors: Edward Dennis, Tony Yaksh, Karin Killerman Lucas, Camilla Svensson, David A. Six, George Kokots, Violetta Constantinou-Kokotou
  • Publication number: 20080206253
    Abstract: Methods are provided for preventing or treating pain in a mammal comprising administering an inhibitor of p38? MAP kinase in a therapeutically effective amount to the mammal in need thereof.
    Type: Application
    Filed: March 14, 2006
    Publication date: August 28, 2008
    Inventors: Xiao-Ying Hua, Camilla Svensson, Tony Lee Yaksh
  • Publication number: 20080039461
    Abstract: The present invention relates to methods for the prevention or treatment of pain by the inhibition of p38 MAP kinase.
    Type: Application
    Filed: December 28, 2006
    Publication date: February 14, 2008
    Inventors: Andrew Protter, Camilla Svensson, Tony Yaksh, Barbara Cordell, Sundeep Dugar
  • Publication number: 20050148549
    Abstract: Specific, highly potent 2-oxo-amide based inhibitors of phospholipase A2 (PLA2) activity are provided. A role for PLA2 activity in spinally mediated inflammatory processes is established, and a method for treating hyperalgesia and other inflammatory conditions associated with PLA2 activity is provided.
    Type: Application
    Filed: March 7, 2003
    Publication date: July 7, 2005
    Inventors: Edward Dennis, Tony Yaksh, Karin Lucas, Camilla Svensson, David Six, George Kokotos, Violetta Constaninou-Kokotou
  • Publication number: 20040122008
    Abstract: The present invention relates to methods for the prevention or treatment of pain by the inhibition of p38 MAP kinase.
    Type: Application
    Filed: September 5, 2003
    Publication date: June 24, 2004
    Inventors: Andrew A. Protter, Camilla Svensson, Tony Yaksh, Barbara Cordell, Sundeep Dugar